{"pageContent": "Introduction: Salvage ablative therapy (SAT) has been developed as a form of localized treatment for localized recurrence of prostate cancers following radiation therapy. To better address the utility of SAT, prospective clinical trials must address the aspects of accepted standards in the initial evaluation, treatment, follow-up, and outcomes in the oncology community. We undertook this study to achieve consensus on uniform standardized trial design for SAT trials.", "metaData": {"source": "Focal therapy for prostate cancer: a potential strategy to address the problem of overtreatment\nhttps://pubmed.ncbi.nlm.nih.gov/21187566/"}}